Search clinical trials for: Sulfonylureas (SU)

Total 121 results

Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
Haukeland University Hospital
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Unknown

Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR) (SuResponsSUR)

Permanent Neonatal Diabetes Mellitus

Norway
Haukeland University Hospital
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Completed

Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes (SuResponsKIR)

Permanent Neonatal Diabetes Mellitus

Norway
Eli Lilly and Company

Completed

A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Mỹ Đức Hospital
Mỹ Đức Phú Nhuận Hospital

Completed

SU Versus GD for Sperm Preparation in IUI

Infertility

Vietnam
Niran Çoban

Completed

Su Jok Application in After Lumbar Disc Surgery

Pain, Postoperative | Lumbar Disc Herniation | Surgery | Nurse's Role

Turkey
Philipps University Marburg Medical Center

Unknown

Neurofeedback Study ADHD

ADHD

Germany
Columbia University
National Cancer Institute (NCI)

Unknown

Cocinar Para su Salud! (Cook for Your Life!)

Breast Cancer

United States
Royal Devon and Exeter NHS Foundation Trust
Wellcome Trust; Haukeland University Hospital; Hôpital Necker-Enfants Malades

Completed

Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations

Diabetes Mellitus
Novartis Pharmaceuticals

Completed

Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin (ADDONIS)

Type 2 Diabetes Mellitus (T2DM)

France
Vanderbilt University
University of Miami; National Institute on Minority Health and Health Disparities... and other collaborators

Completed

Tailoring a Lifestyle Intervention to Address Obesity Disparities Among Men

Obesity | Weight Loss

United States
Candan DOGAN
Ataturk University

Not yet recruiting

The Effect of Sujok Therapy on Symptom Burden and Comfort Level in Patients Undergoing Hemodialysis Treatment

Dialysis; Complications
GlaxoSmithKline

Active, not recruiting

A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults

Herpes Zoster

United States, Australia, Finland, Germany, Japan, Taiwan, Sweden, Spain, Korea, Republic of, Brazil, Mexico, Italy, Canada, Czechia, Estonia, France, Hong Kong, United Kingdom
GlaxoSmithKline

Recruiting

A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

Herpes Zoster

Italy, Spain, United Kingdom, France
Seoul National University Hospital

Completed

Genetic Variants Replication Study Associated With Dependence on Sulfonylurea in Participants With Type 2 Diabetes

Diabetes Mellitus

Korea, Republic of
GlaxoSmithKline

Active, not recruiting

A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response

Herpes Zoster

Spain, Canada, Belgium, Finland, Korea, Republic of, Panama, Taiwan
Mayo Clinic

Enrolling by invitation

A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children

Intravenous Access

United States
Changhua Christian Hospital

Completed

Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas

Type 2 Diabetes Mellitus | Proteinuria
Shiga University
Osaka University; Kanazawa Medical University; Nagahama Red Cross Hospital; Nagahama... and other collaborators

Unknown

Shiga Progression of Diabetes, Nephropathy and Retinopathy (SHIP-DINER)

Type 2 Diabetes Mellitus

Japan
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

Herpes Zoster | Herpes Zoster Vaccine

Canada, Spain, Korea, Republic of, United Kingdom, France, Czechia
Saglik Bilimleri Universitesi

Not yet recruiting

The Effect of Su-Jok Application and Progressive Muscle Relaxation Exercises in Coping With Premenstrual Syndrome

Premenstrual Syndrome
Erbe Elektromedizin GmbH

Recruiting

Feasibility of Cryobiopsy From the Bile Duct - CRYLEO (CRYLEO)

Neoplasms, Bile Duct

Germany
Zhong Wang

Suspended

Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study

Adverse Drug Event | Adverse Drug Reaction | Chinese Medicine | Anaphylactic Reaction

China
GlaxoSmithKline

Completed

A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India

Herpes Zoster

India
Eli Lilly and Company

Completed

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Merck Sharp & Dohme LLC

Completed

The OBSTACLE Hypoglycemia Study (MK-0000-158)

Type 2 Diabetes
DSM Nutritional Products, Inc.

Completed

Phototoxicity Potential of 6% Bemotrizinol

Phototoxic Response

United States
Royal Devon and Exeter NHS Foundation Trust
University of Chicago; University of Bergen; University of Rome Tor Vergata

Recruiting

Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome (iDEND)

Epilepsy | Intellectual Disability | ADHD | Neurodevelopmental Disorders | Autism Spectrum Disorder | Development Delay

United States, United Kingdom, Italy, Norway
Cinnagen

Unknown

Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes

Diabetes Mellitus, Type 2
University of Puerto Rico
National Institutes of Health (NIH)

Recruiting

Chronic-disease Self-management Program in Patients Living With Long-COVID in Puerto Rico

Long Covid19

Puerto Rico
GlaxoSmithKline

Completed

Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older

Herpes Zoster

Germany, Czechia, Sweden
GlaxoSmithKline

Completed

Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.

Herpes Zoster

United States, Australia, Germany, Spain, Finland, Japan, Taiwan, Sweden, Korea, Republic of, Hong Kong, Mexico, Canada, Italy, France, Brazil, Estonia, United Kingdom, Czechia
GlaxoSmithKline

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) Who Had Prior Episode of Shingles

Herpes Zoster

Spain, Panama, Mexico, Russian Federation, Finland, Estonia, Hong Kong, United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Japan
University Hospital, Gentofte, Copenhagen

Completed

The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Denmark
NYU Langone Health

Recruiting

Safety of the Herpes Zoster Subunit Vaccine in Lupus

Systemic Lupus Erythematosus

United States
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus (GLIDKIR6-2)

Diabetes Mellitus

France
GlaxoSmithKline

Completed

Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age

Herpes Zoster

United States
Solasia Pharma K.K.
Solasia Medical Information Consulting (Shanghai) Co. Ltd.

Completed

A Trial of Episil® Oral Liquid in Cancer Patients Suffering From Chemotherapy- and/or Radiation-induced Oral Mucositis

Chemotherapy- and/or Radiation-induced Oral Mucositis

China
Kaiser Permanente
Patient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaborators

Recruiting

Comparison of Type 2 Diabetes Pharmacotherapy Regimens (ON TARGET DM)

Cardiovascular Diseases | Type 2 Diabetes Mellitus

United States
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier

Herpes Zoster

United States
China Medical University Hospital

Completed

Effect of Su-Man Formula Massage Oil Acupressure on Sleep Quality and Anxiety in Patients With Insomnia

Insomnia

Taiwan
All India Institute of Medical Sciences, Bhubaneswar
Chemical Resources

Completed

Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes

Type-2 Diabetes Mellitus

India
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer

Pancreatic Cancer | Pancreatic Cancer Metastatic | Pancreatic Ductal Adenocarcinoma | Pancreatic Carcinoma | Metastatic Pancreatic Cancer | Metastatic Pancreatic Ductal Adenocarcinoma

United States
Takeda

Completed

Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy (ADD)

Type II Diabetes Mellitus

Korea, Republic of
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster

Herpes Zoster

Russian Federation, Canada
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Herpes Zoster

United States, Germany, Estonia, Canada
University of Colorado, Denver
GlaxoSmithKline

Completed

Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds

Herpes Zoster | Shingles

United States
The First Affiliated Hospital of Guangzhou Medical...

Unknown

Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma

Asthma

China
All India Institute of Medical Sciences, Bhubaneswar

Completed

Effect of Folic Acid and Vitamin B12 Supplementation in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2

India

Search clinical trials for: Sulfonylureas (SU)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations